Table 2.
Age (Years) |
Comorbidities | FAF patterns | OCT Findings | Hospitalization | IOT | Anticoagulation | Antibiotic | D-dimer | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Right eye | Left eye | Right eye | Left eye | ||||||||
1 | 51 | None | HypoFAF | HypoFAF | RPE irregularity | RPE elevation | N | N | N | N | N |
2 | 82 | None | Hypo-hyper-FAF | Isolated areas of HypoFAF and HyperFAF | Choroidal irregularity with area of RPE disruption and subretinal fluid | Area of cellular loss at the level of the ellipsoid zone | Y | N | – | – | – |
3 | 51 | None | HypoFAF | None | Cystoid spaces in the interdigitation zone | None | N | N | N | N | N |
4 | 63 | High blood pressure and diabetes | None | HypoFAF | None | Cellular loss at ellipsoid zone | Y | Y | Y | N | 1.20 ng/mL |
5 | 53 | None | Isolated areas of HyperFAF and isolated areas of HypoFAF | Isolated areas of HyperFAF and isolated areas of HypoFAF | Disruption of the interdigitation zone | Disruption of the interdigitation zone with local retinal thinning | Y | N | N | Y | 0.45 ng/mL |
6 | 86 | None | Hypo-hyper-FAF | Hypo-hyper-FAF | Disruption of the interdigitation zone, outer segment layer and ellipsoid zone | Disruption of the interdigitation zone, outer segment layer and ellipsoid zone | Y | N | N | Y | 1.63 ng/mL |
7 | 51 | High blood pressure and diabetes | HypoFAF | HyperFAF | RPE irregularity with subretinal liquid and disruption of the ellipsoid zone | RPE irregularity with adjacent cell loss at the ellipsoid zone | Y | N | N | N | 0.53ng/mL |
8 | 69 | None | Hypo-hyper-FAF | HypoFAF | RPE elevation | RPE irregularity | Y | N | N | Y | N |
9 | 66 | High blood pressure | HypoFAF | None | External limiting membrane irregularity | None | Y | N | Y | Y | 0.61 ng/mL |
10 | 49 | None | Hypo-hyper-FAF | HypoFAF | Retinal thinning and loss of external retina and outer nuclear layers | RPE elevation and outer retinal layer loss | No | No | No | No | – |
11 | 57 | High blood pressure | None | Hypo-hyper-FAF | None | Retinal thinning due to loss of external retinal and outer nuclear layers | Y | N | N | Y | 0.71 ng/mL |
12 | 62 | High blood pressure | HypoFAF | None | Retinal Pigmented Epithelial Detachment and adjacent loss of ellipsoid zone | None | Y | N | Y | N | – |
13 | 48 | None | Isolated areas of HyperFAF and HypoFAF | None | RPE elevation | None | Y | N | – | – | 0.85 ng/mL |
14 | 31 | None | None | HypoFAF | None | Disruption of the interdigitation and outer segment layers and adjacent scarring | -- | -- | N | N | N |
15 | 35 | None | HypoFAF | None | None | None | N | N | N | Y | N |
16 | 58 | High blood pressure | HypoFAF, with surrounding area of HyperFAF | None | Disruption of external retina with adjacent scarring | None | Y | N | Y | Y | 0.93 ng/mL |
17 | 34 | None | HypoFAF | HypoFAF | RPE and ellipsoid irregularity | RPE irregularity and elevation | Y | N | N | N | 1.80 ng/mL |
18 | 41 | None | Hypo-hyper-FAF | None | Choroidal elevetaion | None | N | N | N | N | N |